| Product Code: ETC12836030 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Infectious Vaccines Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Infectious Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Infectious Vaccines Market - Industry Life Cycle |
3.4 Australia Infectious Vaccines Market - Porter's Five Forces |
3.5 Australia Infectious Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Infectious Vaccines Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Australia Infectious Vaccines Market Revenues & Volume Share, By End-Use, 2021 & 2031F |
3.8 Australia Infectious Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Infectious Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Australia |
4.2.2 Government initiatives to promote vaccination programs |
4.2.3 Growing awareness about the importance of vaccination in preventing diseases |
4.3 Market Restraints |
4.3.1 High cost associated with vaccine development and production |
4.3.2 Stringent regulatory requirements for vaccine approval |
4.3.3 Vaccine hesitancy and misinformation among the population |
5 Australia Infectious Vaccines Market Trends |
6 Australia Infectious Vaccines Market, By Types |
6.1 Australia Infectious Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Infectious Vaccines Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Australia Infectious Vaccines Market Revenues & Volume, By Live Attenuated Vaccines, 2021 - 2031F |
6.1.4 Australia Infectious Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021 - 2031F |
6.1.5 Australia Infectious Vaccines Market Revenues & Volume, By mRNA Vaccines, 2021 - 2031F |
6.2 Australia Infectious Vaccines Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Infectious Vaccines Market Revenues & Volume, By COVID-19, 2021 - 2031F |
6.2.3 Australia Infectious Vaccines Market Revenues & Volume, By Influenza, 2021 - 2031F |
6.2.4 Australia Infectious Vaccines Market Revenues & Volume, By Hepatitis, 2021 - 2031F |
6.3 Australia Infectious Vaccines Market, By End-Use |
6.3.1 Overview and Analysis |
6.3.2 Australia Infectious Vaccines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Australia Infectious Vaccines Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.3.4 Australia Infectious Vaccines Market Revenues & Volume, By Government Immunization Programs, 2021 - 2031F |
6.4 Australia Infectious Vaccines Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Australia Infectious Vaccines Market Revenues & Volume, By Public Health Agencies, 2021 - 2031F |
6.4.3 Australia Infectious Vaccines Market Revenues & Volume, By Private Clinics, 2021 - 2031F |
7 Australia Infectious Vaccines Market Import-Export Trade Statistics |
7.1 Australia Infectious Vaccines Market Export to Major Countries |
7.2 Australia Infectious Vaccines Market Imports from Major Countries |
8 Australia Infectious Vaccines Market Key Performance Indicators |
8.1 Vaccine uptake rate among target populations |
8.2 Number of reported cases of infectious diseases in Australia |
8.3 Percentage of healthcare professionals recommending vaccinations |
8.4 Research and development investment in new vaccine technologies |
8.5 Public health campaigns promoting vaccination awareness |
9 Australia Infectious Vaccines Market - Opportunity Assessment |
9.1 Australia Infectious Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Infectious Vaccines Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Australia Infectious Vaccines Market Opportunity Assessment, By End-Use, 2021 & 2031F |
9.4 Australia Infectious Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Infectious Vaccines Market - Competitive Landscape |
10.1 Australia Infectious Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Australia Infectious Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here